Literature DB >> 15629970

Long eyelashes in a case series of 93 children with vernal keratoconjunctivitis.

Neri Pucci1, Elio Novembre, Enrico Lombardi, Cristina Massai, Roberto Bernardini, Roberto Caputo, Luciana Campa, Cinzia de Libero, Alberto Vierucci.   

Abstract

OBJECTIVE: Vernal keratoconjunctivitis (VKC) is a chronic conjunctivitis that affects children mainly in temperate areas, with exacerbations in spring and summer. Eyelashes provide natural protection for the eyes from sunshine, wind, and foreign bodies. These factors induce a worsening of signs and symptoms in VKC, whereas mechanical protection of the eyes produces relief. The aim of this study was to evaluate eyelash length in a large series of VKC patients and in age- and gender-matched healthy subjects.
METHODS: Upper eyelash length was measured in 93 VKC patients (mean age: 8.7 years; range: 4-18 years) with a digital caliper. History, clinical form, type of presentation, degree of severity, and drug therapy were evaluated. Skin tests and serum-specific immunoglobulin E for common allergens, serum-total immunoglobulin E, peripheral blood eosinophil counts, and serum eosinophil cationic protein were determined. Two age- and gender-matched control subjects for each VKC patient underwent the same eyelash measurement.
RESULTS: The upper eyelashes were significantly longer in VKC patients than in control subjects (mean +/- SD: 8.9 +/- 1.17 mm vs 7.9 +/- 1.07 mm). In healthy subjects, a negative correlation was found between eyelash length and age. With multivariate analysis, unlike control subjects, the eyelash length in VKC patients did not correlate with age, was positively correlated with the degree of severity of VKC, and was negatively correlated with the use of topical cyclosporine.
CONCLUSIONS: Patients with VKC had longer eyelashes than healthy matched subjects. The ocular inflammation, by unknown chemical mediators, was likely responsible for the excessive eyelash growth. The finding may represent a defensive mechanism against physical agents that might have a crucial role in the etiopathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15629970     DOI: 10.1542/peds.2004-1555

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Eyelash trichomegaly following treatment with erlotinib in a non-small cell lung cancer patient: A case report and literature review.

Authors:  Shan-Bing Wang; Kai-Jian Lei; Jia-Pei Liu; Yu-Ming Jia
Journal:  Oncol Lett       Date:  2015-05-26       Impact factor: 2.967

2.  Bimatoprost in the treatment of eyelash hypotrichosis.

Authors:  Simon K Law
Journal:  Clin Ophthalmol       Date:  2010-04-26

3.  Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C.

Authors:  Karen W Gripp; Elizabeth Hopkins; Katia Sol-Church; Deborah L Stabley; Marni E Axelrad; Daniel Doyle; William B Dobyns; Cindy Hudson; John Johnson; Romano Tenconi; Gail E Graham; Ana Berta Sousa; Raoul Heller; Maria Piccione; Giovanni Corsello; Gail E Herman; Marco Tartaglia; Angela E Lin
Journal:  Am J Med Genet A       Date:  2011-03-15       Impact factor: 2.802

4.  Increased incidence of thyroid dysfunction and autoimmunity in patients with vernal keratoconjunctivitis.

Authors:  Stefano Stagi; Neri Pucci; Laura Di Grande; Cinzia de Libero; Roberto Caputo; Stefano Pantano; Ivan Mattei; Francesca Mori; Maurizio de Martino; Elio Novembre
Journal:  Int J Endocrinol       Date:  2014-07-20       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.